Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.52+0.09 (+6.29%)
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Zhengye Biotechnology's enterprise value was $82.57M on Nov 11, 2026, against $109.52M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $82.57M | +23.7% |
| 2025 | Dec 31, 2025 | $66.76M | – |
See a number that looks wrong?